Patent · US Active

Substituted benzimidazoles

US9388140B2 · kind B2 · utility

3Cited by

0References

18Claims

0Family size

Assignee

Bayer Intellectual Property GmbH · DE

Inventors

Ulrich Klar · Berlin, DE
Marcus Koppitz · Berlin, DE
Duy Nguyen · Berlin, DE
Dirk Kosemund · Berlin, DE
Roland Neuhaus · Berlin, DE
Gerhard Siemeister · Berlin, DE

Key dates

Filing date	Mar 28, 2012
Grant date	Jul 12, 2016
Priority date	—
Expiry date	Dec 24, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to substituted benzimidazole compounds of general formula (I) in which R3, R5 and A are as defined in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative and/or angiogenesis disorder, as a sole agent or in combination with other active ingredients.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.